Haemonetics Corp.: FDA filings under this applicant name

FDA lists 36 510(k) clearances under 3 spellings of the applicant name “Haemonetics Corp.” (first 1980, latest 2025), across 10 product codes in 6 review panels. Median 510(k) review time under this name: 72 days. Since 2017 the median was 154 days, against 201 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

510(k) clearances per year

YearClearancesMedian review days
2012288
20130—
20140—
20150—
20161118
20172274
20180—
20191175
20200—
20210—
20221154
20230—
20241266
2025229
20260—

Review time against the same product codes

Since 2017, 510(k)s cleared under the name Haemonetics Corp. took a median 154 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 201 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
CACApparatus, Autotransfusion1818
JPASystem, Multipurpose For In Vitro Coagulation Studies55
KSRContainer, Empty, For Collection & Processing Of Blood & Blood Components33
BTAPump, Portable, Aspiration (Manual Or Powered)22
FPASet, Administration, Intravascular22
FRNPump, Infusion22
CAKMicrofilter, Blood Transfusion11
CALLaryngoscope, Non-Rigid11
GAANeedle, Aspiration And Injection, Disposable11
LKNSeparator, Automated, Blood Cell And Plasma, Therapeutic11

Review panels

Most recent Haemonetics Corp. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K251024TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay CartridgeJPA2025-04-3028
K243858TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay CartridgeJPA2025-01-1530
K232018Citrated: K, KH, RTH, FFHJPA2024-03-29266
K221722Haemonetics Cell Saver Elite/Elite+ Autotransfusion System (CSE-E-US/CSE-EW-US)CAC2022-11-15154
K183160TEG 6s Hemostasis System, TEG 6s Citrated: K, RT, FF Assay CartridgeJPA2019-05-09175
K160502TEG 6s Hemostasis SystemJPA2017-04-19421
K162423Haemonetics Cell Saver Elite/Elite+ Autotransfusion SystemCAC2017-01-03126
K160197Haemonetics Cell Saver Elite Autotransfusion SystemCAC2016-05-24118
K122262ORTHOPAT ADVANCE PERIOPERATIVE AUTOTRANSFUSION SYSTEMCAC2012-10-2590
K120586CELL SAVER ELITECAC2012-05-2285

26 earlier clearances. See the full list in Caduvo.

Recalls

46 product recalls in 17 recall events; 2 initiated in the last five years. Most recent: 2022-04-26.

1 product recall in 1 recall event filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: Bovie Medical Corporation (1).

These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Device clinical trials

An industry sponsor named Haemonetics Corp. is the lead sponsor of 5 device studies on ClinicalTrials.gov (0 active or recruiting). Most recent:

SEC filings

HAEMONETICS CORP (HAE): EDGAR filings, CIK 313143. An SEC registrant with the same name, matched by name only.

Related HCPCS codes

HCPCS Level II codes whose descriptors match the device names of the product codes filed under Haemonetics Corp. (a text match, not an official crosswalk):

FDA spellings included

FDA records this applicant under 3 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:

Frequently asked questions

How many FDA 510(k) clearances are listed under Haemonetics Corp.?

FDA lists 36 510(k) clearances under 3 spellings of the applicant name “Haemonetics Corp.” (first 1980, latest 2025), across 10 product codes in 6 review panels. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Haemonetics Corp.?

The median time from FDA receipt to decision across 510(k)s cleared under the name Haemonetics Corp. is 72 days. Since 2017: 154 days, versus 201 days for all cleared 510(k)s in the same product codes.

Which FDA product codes appear under Haemonetics Corp.?

The most frequent FDA product codes under this applicant name are CAC (Apparatus, Autotransfusion, 18); JPA (System, Multipurpose For In Vitro Coagulation Studies, 5); KSR (Container, Empty, For Collection & Processing Of Blood & Blood Components, 3).

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.

All FDA device companies · FDA product code lookup